TY - JOUR T1 - Bad bots: how should doctors respond to untested technologies? JF - British Journal of General Practice JO - Br J Gen Pract SP - 297 LP - 297 DO - 10.3399/bjgp19X703901 VL - 69 IS - 683 AU - Stephen H Bradley Y1 - 2019/06/01 UR - http://bjgp.org/content/69/683/297.abstract N2 - The extraordinary rise and fall of Silicon Valley start-up Theranos is recounted in the unlikely page-turner Bad Blood.1 Only a few years ago, Theranos, and its iconic founder and supposed genius Elizabeth Holmes, were celebrated for their game-changing technology that was set to revolutionise diagnosis. With its promise of machines that could perform hundreds of blood tests on a single drop of blood, Theranos was valued at $9 bn, while Holmes was fêted with fame, honours, and awards. Her board was stacked with dignitaries such as elder statesmen Henry Kissinger and George Shultz. Such luminaries, along with investors like Rupert Murdoch, were all captivated by Holmes’s vision of painless, accurate, and cheap diagnostics that would save lives and make them billions.The … ER -